Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Cohu, Inc. (COHU) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cohu, Inc. (COHU) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for November 18th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 18th:
Cohu, Inc. (COHU - Free Report) : This provider of semiconductor test and inspection handlers and other equipment has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Cohu, Inc. Price and Consensus
Cohu, Inc. price-consensus-chart | Cohu, Inc. Quote
Cohu’s shares gained 31.9% over the last one month more than S&P 500’s rise of 4.5%. The company possesses a Momentum Score of A.
Cohu, Inc. Price
Cohu, Inc. price | Cohu, Inc. Quote
Ascendis Pharma A/S (ASND - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
Ascendis Pharma A/S Price and Consensus
Ascendis Pharma A/S price-consensus-chart | Ascendis Pharma A/S Quote
Ascendis Pharma’s shares gained 13.8% over the last one month. The company possesses a Momentum Score of B.
Ascendis Pharma A/S Price
Ascendis Pharma A/S price | Ascendis Pharma A/S Quote
Aspen Group, Inc. (ASPU - Free Report) : This online provider of higher education services has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.3% over the last 60 days.
Aspen Group Inc. Price and Consensus
Aspen Group Inc. price-consensus-chart | Aspen Group Inc. Quote
Aspen’s shares gained 19.6% over the last one month. The company possesses a Momentum Score of B.
Aspen Group Inc. Price
Aspen Group Inc. price | Aspen Group Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.5% per year. So be sure to give these hand-picked 7 your immediate attention.
See them now >>